P1483: LONG-TERM IMPACT OF OLIPUDASE ALFA ENZYME REPLACEMENT THERAPY ON SPLEEN VOLUME AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN AND ADULTS WITH CHRONIC ACID SPHINGOMYELINASE DEFICIENCY

• Jesus Villarrubia,
• Jaya Ganesh,
• Roberto Giugliani,
• Nathalie Guffon,
• Eugen Mengel,
• Maurizio Scarpa,
• Melissa Wasserstein,
• Nicole Armstrong,
• Gasparic Maja,
• Yong Kim,
• Holly Wong,
• Abhimanyu Yarramaneni

Affiliations

Jesus Villarrubia

1 Ramón y Cajal Hospital, Hematology, Madrid, Spain

Jaya Ganesh

2 Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences, New York, NY, United States

Roberto Giugliani

3 Genetics UFRGS, Medical Genetics Service HCPA, DASA and Casa dos Raros, Porto Alegre, Brazil

Nathalie Guffon

4 Hôpital Femme Mère Enfant- Hospices Civils de Lyon, Centre de Référence des Maladies Héréditaires du Métabolisme, Lyon, France

Eugen Mengel

5 Institute of Clinical Science for Lysosomal Storage Disorders, SphinCS GmbH, Hochheim, Germany

Maurizio Scarpa

6 University Hospital of Udine, Regional Coordinator Centre for Rare Diseases, Udine, Italy

Melissa Wasserstein

7 Albert Einstein College of Medicine, Children’s Hospital at Montefiore, Bronx, NY, United States

Nicole Armstrong

8 Sanofi, Cambridge, MA, United States

Gasparic Maja

9 Sanofi, Amsterdam, The Netherlands

Yong Kim

10 Sanofi, Paris, France

Holly Wong

8 Sanofi, Cambridge, MA, United States

Abhimanyu Yarramaneni

11 Sanofi, Bridgewater, NJ, United States